Vis enkel innførsel

dc.contributor.advisorJohnsen, Pål Jarle
dc.contributor.authorPat, Gina
dc.date.accessioned2015-07-08T05:12:33Z
dc.date.accessioned2017-05-15T07:56:22Z
dc.date.available2017-05-15T07:56:22Z
dc.date.issued2015-05-13
dc.description.abstractResistance towards antimicrobial agents is an increasing medical problem nowadays caused by the elimination of susceptible bacteria leaving only the resistant ones to survive and evolve. Evolution through mutations that lead to antibiotic resistance in bacteria increases the diversity of bacterial genomes. Under antibiotic treatment, these mutations might be advantageous for the bacteria, but disadvantage in the absence of antibiotic due to fitness cost. By understanding, how mutations can have an impact on the fitness cost for individual resistance determinants and the interactions that occur within one genetic background can foster our understanding of epistasis. The importance of understanding epistatic interactions between genetic determinants that are responsible for a resistant phenotype can be essential in the treatment of bacterial infections with antimicrobial drugs. In this study, mutants of clinical Escherichia coli strains with reduced susceptibility towards trimethoprim and/or ciprofloxacin were generated to test whether epistatic interactions in certain combinations of mutants existed. Growth curve measurements were used to calculate the relative generation time as a measure of fitness. The result revealed that the generation time of double mutant TP+CIP22 was reduced with 7 minutes compared to the single mutant TP22, resulting in a potentially positive epistatic interaction. However, a negative epistatic interaction may have occurred due to a decrease in minimal inhibitory concentration (MIC) determined for trimethoprim in all double mutants (TP+CIP) compared to the respective single mutants (TP). The results provided here promote our understanding of epistatic interactions in bacteria. Hopefully, together with findings of further experiments, they will be implemented in innovative guidelines for antibiotic treatment.en_US
dc.identifier.urihttps://hdl.handle.net/10037/11019
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2015 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)en_US
dc.subject.courseIDFAR-3901en_US
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk mikrobiologi: 715en_US
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical microbiology: 715en_US
dc.titleExperimental explorations of general patterns of epistatic interactions in clinical Escherichia coli isolatesen_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)